trimethoprim has been researched along with Intraventricular Septal Defects in 1 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iki, Y | 1 |
| Hata, A | 1 |
| Fukuyama, M | 1 |
| Yoshioka, T | 1 |
| Watanabe, K | 1 |
| Asari, S | 1 |
| Hata, D | 1 |
1 other study available for trimethoprim and Intraventricular Septal Defects
| Article | Year |
|---|---|
Successful Conservative Treatment of Mycotic Pulmonary Artery Aneurysms Caused by MRSA Bacteremia.
Topics: Aneurysm, Infected; Anti-Bacterial Agents; Bacteremia; Clindamycin; Conservative Treatment; Drug Com | 2019 |